glp-1 kidney outcomes news The Impact of Glucagon-Like Peptide-1 Receptor... : Clinical Journal of the American Society of Nephrology Kidney Outcomes With Glucagon-Like Peptide-1

Glucagon-like peptide-1 receptor agonists may be more effective than metformin in reducing dementia risk, particularly Alzheimer's disease, in patients with type 2 diabetes Esteban Jodar Gimenos Post Glucagon-like peptide-1 receptor agonists may be more effective than metformin in reducing dementia risk, particularly Alzheimer's disease, in patients with type 2 diabetes

Hims & Hers is mass marketing unapproved knock-off versions of Wegovy and Ozempic that evade the FDAs gold standard review processthats dangerous and deceptive to patients, and undermines the scientific innovation and regulatory rigor in place to ensure these treatments are safe and effective

At Set Point Medical Weight Loss Clinic, we are committed to providing cutting-edge treatments to help our patients achieve their weight management goals

An area of ongoing research is the cascading effect taking a GLP-1 can have on the body